Direct In Vivo Human Intestinal Permeability (Peff ) Determined with Different Clinical Perfusion and Intubation Methods.

Regional in vivo human intestinal effective permeability (Peff ) is calculated by measuring the disappearance rate of substances during intestinal perfusion. Peff is the most relevant parameter in the prediction of rate and extent of drug absorption from all parts of the intestine. Today, human intestinal perfusions are not performed on a routine basis in drug development. Therefore, it would be beneficial to increase the accuracy of the in vitro and in silico tools used to evaluate the intestinal Peff of novel drugs. This review compiles historical Peff data from 273 individual measurements of 80 substances from 61 studies performed in all parts of the human intestinal tract. These substances include: drugs, monosaccharaides, amino acids, dipeptides, vitamins, steroids, bile acids, ions, fatty acids, and water. The review also discusses the determination and prediction of Peff using in vitro and in silico methods such as quantitative structure-activity relationship, Caco-2, Ussing chamber, animal intestinal perfusion, and physiologically based pharmacokinetic (PBPK) modeling. Finally, we briefly outline how to acquire accurate human intestinal Peff data by deconvolution of plasma concentration-time profiles following regional intestinal bolus dosing.

[1]  Daisuke Nakai,et al.  Human small intestinal and colonic tissue mounted in the Ussing chamber as a tool for characterizing the intestinal absorption of drugs. , 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[2]  L. Salphati,et al.  Evaluation of a single‐pass intestinal‐perfusion method in rat for the prediction of absorption in man , 2001, The Journal of pharmacy and pharmacology.

[3]  H. Lennernäs,et al.  The effect of ketoconazole on the in vivo intestinal permeability of fexofenadine using a regional perfusion technique. , 2003, British journal of clinical pharmacology.

[4]  M. Kataoka,et al.  Measurement of Drug Concentration in the Stomach After Intragastric Administration of Drug Solution to Healthy Volunteers: Analysis of Intragastric Fluid Dynamics and Drug Absorption , 2012, Pharmaceutical Research.

[5]  G. Ecker,et al.  Evidence-based approach to assess passive diffusion and carrier-mediated drug transport. , 2012, Drug discovery today.

[6]  W. Wahli,et al.  Regional variations in ABC transporter expression along the mouse intestinal tract. , 2004, Physiological genomics.

[7]  H. Lennernäs,et al.  The influence of caprate on rectal absorption of phenoxymethylpenicillin: experience from an in‐vivo perfusion in humans , 2002, The Journal of pharmacy and pharmacology.

[8]  H. Lennernäs,et al.  Increased understanding of intestinal drug permeability determined by the LOC-I-GUT approach using multislice computed tomography. , 2009, Molecular pharmaceutics.

[9]  Rafael Gozalbes,et al.  QSAR-based permeability model for drug-like compounds. , 2011, Bioorganic & medicinal chemistry.

[10]  D. Kell,et al.  The promiscuous binding of pharmaceutical drugs and their transporter-mediated uptake into cells: what we (need to) know and how we can do so. , 2013, Drug discovery today.

[11]  Caroline A. Lee,et al.  P-glycoprotein related drug interactions: clinical importance and a consideration of disease states , 2010, Expert opinion on drug metabolism & toxicology.

[12]  L. Knutson,et al.  A new technique for segmental jejunal perfusion in man. , 1989, The American journal of gastroenterology.

[13]  K. Luthman,et al.  Effect of molecular charge on intestinal epithelial drug transport: pH-dependent transport of cationic drugs. , 1999, The Journal of pharmacology and experimental therapeutics.

[14]  M. Lucas,et al.  The magnitude and distribution of the acid microclimate in proximal jejunum and its relation to luminal acidification , 1978, Proceedings of the Royal Society of London. Series B. Biological Sciences.

[15]  Marjo Yliperttula,et al.  Computational prediction of oral drug absorption based on absorption rate constants in humans. , 2006, Journal of medicinal chemistry.

[16]  Hans Lennernäs,et al.  Toward an increased understanding of the barriers to colonic drug absorption in humans: implications for early controlled release candidate assessment. , 2009, Molecular pharmaceutics.

[17]  G. Cook Impairment of glycine absorption by glucose and galactose in man , 1971, The Journal of physiology.

[18]  J. Diamond,et al.  Lithium absorption in tight and leaky segments of intestine , 2005, The Journal of Membrane Biology.

[19]  G. Amidon,et al.  Human Jejunal Permeability of Two Polar Drugs: Cimetidine and Ranitidine , 2001, Pharmaceutical Research.

[20]  Tanya Coleman,et al.  Pancreatoduodenectomy as a source of human small intestine for Ussing chamber investigations and comparative studies with rat tissue , 2011, Biopharmaceutics & drug disposition.

[21]  K. Andersson,et al.  Absorption of digoxin in man after oral and intrasigmoid administration studied by portal vein catheterization , 1975, European Journal of Clinical Pharmacology.

[22]  Leslie Z Benet,et al.  In Vivo Modulation of Intestinal CYP3A Metabolism by P-Glycoprotein: Studies Using the Rat Single-Pass Intestinal Perfusion Model , 2003, Journal of Pharmacology and Experimental Therapeutics.

[23]  Martin Bergstrand,et al.  PBPK models for the prediction of in vivo performance of oral dosage forms. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[24]  H. Lennernäs,et al.  The lack of effect of induced net fluid absorption on the in vivo permeability of terbutaline in the human jejunum. , 1995, Journal of drug targeting.

[25]  G. Cook Intestinal absorption rate of L‐methionine in man and the effect of glucose in the perfusing fluid , 1972, The Journal of physiology.

[26]  T. Gramatté,et al.  Paracetamol absorption from different sites in the human small intestine. , 1994, British journal of clinical pharmacology.

[27]  H. Schedl,et al.  Absorption of L-methionine from the human small intestine. , 1968, The Journal of clinical investigation.

[28]  Kazuya Nakao,et al.  In silico Prediction of Human Oral Absorption Based on QSAR Analyses of PAMPA Permeability , 2009, Chemistry & biodiversity.

[29]  J. Kovarik,et al.  Longitudinal assessment of a P‐glycoprotein–mediated drug interaction of valspodar on digoxin , 1999, Clinical pharmacology and therapeutics.

[30]  Lawrence X. Yu,et al.  High-permeability criterion for BCS classification: segmental/pH dependent permeability considerations. , 2010, Molecular pharmaceutics.

[31]  K. Takács-Novák,et al.  Interlaboratory study of log P determination by shake-flask and potentiometric methods. , 1996, Journal of pharmaceutical and biomedical analysis.

[32]  Christer Tannergren,et al.  Comprehensive study on regional human intestinal permeability and prediction of fraction absorbed of drugs using the Ussing chamber technique. , 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[33]  D. Mercer,et al.  Protein digestion in human intestine as reflected in luminal, mucosal, and plasma amino acid concentrations after meals. , 1973, The Journal of clinical investigation.

[34]  R. Zurier,et al.  Relationship between net water absorption and hexanoic acid absorption from the intact human jejunum , 1968, The American Journal of Digestive Diseases.

[35]  J. Dietschy,et al.  Experimental demonstration of the effect of the unstirred water layer on the kinetic constants of the membrane transport ofd-glucose in rabbit jejunum , 1980, The Journal of Membrane Biology.

[36]  Robert G. Hahn,et al.  Role of Variability in Explaining Ethanol Pharmacokinetics , 2003, Clinical pharmacokinetics.

[37]  G. Cook Glucose absorption kinetics in Zambian African patients with and without systemic bacterial infections , 1971, Gut.

[38]  L. Benet,et al.  Distinguishing between the Permeability Relationships with Absorption and Metabolism To Improve BCS and BDDCS Predictions in Early Drug Discovery , 2014, Molecular pharmaceutics.

[39]  M. Zeidel,et al.  Determinants of apical membrane permeabilities of barrier epithelia. , 1994, The American journal of physiology.

[40]  H Lennernäs,et al.  Membrane transport of drugs in different regions of the intestinal tract of the rat. , 1998, Journal of pharmaceutical sciences.

[41]  H. Lennernäs,et al.  The Influence of Net Water Absorption on the Permeability of Antipyrine and Levodopa in the Human Jejunum , 1994, Pharmaceutical Research.

[42]  M. Hedeland,et al.  Effect of erythromycin on the absorption of fexofenadine in the jejunum, ileum and colon determined using local intubation in healthy volunteers. , 2006, International journal of clinical pharmacology and therapeutics.

[43]  A. Zinsmeister,et al.  Relationship of motility to flow of contents in the human small intestine. , 1982, Gastroenterology.

[44]  H. Lennernäs,et al.  Enterohepatic Disposition of Rosuvastatin in Pigs and the Impact of Concomitant Dosing with Cyclosporine and Gemfibrozil , 2009, Drug Metabolism and Disposition.

[45]  Erik Sjögren,et al.  In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim. , 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[46]  P. Dawson Role of the intestinal bile acid transporters in bile acid and drug disposition. , 2011, Handbook of experimental pharmacology.

[47]  J. Desgrosellier,et al.  4-(N,N-dipropylamino)benzaldehyde inhibits the oxidation of all-trans retinal to all-trans retinoic acid by ALDH1A1, but not the differentiation of HL-60 promyelocytic leukemia cells exposed to all-trans retinal , 2002, BMC pharmacology.

[48]  H. Lennernäs,et al.  Is the Jejunal Permeability in Rats Age-Dependent? , 1997, Pharmaceutical Research.

[49]  S. Chaussade,et al.  Metformin in the digestive tract. , 1988, Diabetes research and clinical practice.

[50]  M. Perko Duplex ultrasound for assessment of superior mesenteric artery blood flow. , 2001, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[51]  W. Kirch,et al.  Direct demonstration of small intestinal secretion and site‐dependent absorption of the β‐blocker talinolol in humans , 1996, Clinical pharmacology and therapeutics.

[52]  E. Näslund Gastric Emptying: Comparison of Scintigraphic, Polyethylene Glycol Dilution, and Paracetamol Tracer Assessment Techniques , 2000, Scandinavian journal of gastroenterology.

[53]  Gordon L. Amidon,et al.  Comparison of Human Duodenum and Caco-2 Gene Expression Profiles for 12,000 Gene Sequences Tags and Correlation with Permeability of 26 Drugs , 2002, Pharmaceutical Research.

[54]  T. Bamba,et al.  Effects of pectin on fatty acid and glucose absorption and on thickness of unstirred water layer in rat and human intestine , 1989, Digestive Diseases and Sciences.

[55]  H. Schedl Absorption of steroid hormones from the human small intestine. , 1965, The Journal of clinical endocrinology and metabolism.

[56]  A. Thomson,et al.  Intestinal sugar transport. , 2006, World journal of gastroenterology.

[57]  P. Dawson,et al.  Bile acid transporters , 2009, Journal of Lipid Research.

[58]  W. Summerskill,et al.  TRANSFER OF AMMONIA IN THE HUMAN JEJUNUM. , 1965, The Journal of laboratory and clinical medicine.

[59]  G. Williamson,et al.  Absorption/metabolism of sulforaphane and quercetin, and regulation of phase II enzymes, in human jejunum in vivo. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[60]  Kazuya Nakao,et al.  QSAR study on permeability of hydrophobic compounds with artificial membranes. , 2007, Bioorganic & medicinal chemistry.

[61]  A. Dawson,et al.  Further studies on the perfusion method for measuring intestinal absorption in man: The effects of a proximal occlusive balloon and a mixing segment , 1970, Gut.

[62]  G. Kellett The facilitated component of intestinal glucose absorption , 2001, The Journal of physiology.

[63]  Patrick J. Sinko,et al.  Estimating Human Oral Fraction Dose Absorbed: A Correlation Using Rat Intestinal Membrane Permeability for Passive and Carrier-Mediated Compounds , 2004, Pharmaceutical Research.

[64]  T. Xiang,et al.  Influence of a Transmembrane Protein on the Permeability of Small Molecules Across Lipid Membranes , 2000, The Journal of Membrane Biology.

[65]  D. Levitt,et al.  Physiological measurements of luminal stirring in the dog and human small bowel. , 1990, The Journal of clinical investigation.

[66]  S. Bröer,et al.  Amino acid transport across mammalian intestinal and renal epithelia. , 2008, Physiological reviews.

[67]  H. Ehrén,et al.  Effects of luminal distension and obstruction on the intestinal circulation , 1986, Pediatric Surgery International.

[68]  Charles M Mansbach,et al.  Development and physiological regulation of intestinal lipid absorption. II. Dietary lipid absorption, complex lipid synthesis, and the intracellular packaging and secretion of chylomicrons. , 2007, American journal of physiology. Gastrointestinal and liver physiology.

[69]  J. Wilson,et al.  Surface area of the small intestine in man. , 1967, Gut.

[70]  P. Dahlqvist,et al.  Improved cortisol exposure-time profile and outcome in patients with adrenal insufficiency: a prospective randomized trial of a novel hydrocortisone dual-release formulation. , 2012, The Journal of clinical endocrinology and metabolism.

[71]  J. Kinney,et al.  Absorption of glucose from the colon and rectum. , 1967, Metabolism: clinical and experimental.

[72]  P. Annaert,et al.  INTESTINAL PERFUSION WITH MESENTERIC BLOOD SAMPLING IN WILD-TYPE AND KNOCKOUT MICE , 2009, Drug Metabolism and Disposition.

[73]  Hans Lennernäs,et al.  In Vivo Investigation in Pigs of Intestinal Absorption, Hepatobiliary Disposition, and Metabolism of the 5α-Reductase Inhibitor Finasteride and the Effects of Coadministered Ketoconazole , 2011, Drug Metabolism and Disposition.

[74]  H. Lennernäs,et al.  Comparison between active and passive drug transport in human intestinal epithelial (Caco-2) cells in vitro and human jejunum in vivo , 1996 .

[75]  K. C. Kwan Oral bioavailability and first-pass effects. , 1997, Drug metabolism and disposition: the biological fate of chemicals.

[76]  H Lennernäs,et al.  Human Jejunal Effective Permeability and Its Correlation with Preclinical Drug Absorption Models , 1997, The Journal of pharmacy and pharmacology.

[77]  E. Dimagno,et al.  Fate of pancreatic enzymes during small intestinal aboral transit in humans. , 1986, The American journal of physiology.

[78]  G Folkers,et al.  Estimation of permeability by passive diffusion through Caco-2 cell monolayers using the drugs' lipophilicity and molecular weight. , 1998, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[79]  H. Mekhjian,et al.  Colonic secretion of water and electrolytes induced by bile acids: perfusion studies in man. , 1971, The Journal of clinical investigation.

[80]  H. Lennernäs,et al.  Regional transport and metabolism of ropivacaine and its CYP3A4 metabolite PPX in human intestine , 2003, The Journal of pharmacy and pharmacology.

[81]  C. Binkert,et al.  Feasibility of small bowel flow rate measurement with MRI , 2010, Journal of magnetic resonance imaging : JMRI.

[82]  M. Sherry Ku,et al.  Use of the Biopharmaceutical Classification System in Early Drug Development , 2008, The AAPS Journal.

[83]  T. J. Cook,et al.  Spatial expression patterns of peptide transporters in the human and rat gastrointestinal tracts, Caco-2 In Vitro cell culture model, and multiple human tissues , 2001, AAPS PharmSci.

[84]  H. Lennernäs,et al.  Multiple transport mechanisms involved in the intestinal absorption and first‐pass extraction of fexofenadine , 2003, Clinical pharmacology and therapeutics.

[85]  R. Modigliani,et al.  Absorption of glucose, sodium, and water by the human jejunum studied by intestinal perfusion with a proximal occluding balloon and at variable flow rates , 1971, Gut.

[86]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .

[87]  Bertil Abrahamsson,et al.  A convenient method for local drug administration at predefined sites in the entire gastrointestinal tract: experiences from 13 phase I studies. , 2007, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[88]  H. Lennernäs,et al.  Rat Jejunal Permeability and Metabolism of μ-Selective Tetrapeptides in Gastrointestinal Fluids from Humans and Rats , 1997, Pharmaceutical Research.

[89]  D. Levitt,et al.  Shaking of the intact rat and intestinal angulation diminish the jejunal unstirred layer. , 1992, Gastroenterology.

[90]  G. Cook Impairment of jejunal absorption rate of carnosine by glycylglycine in man in vivo. , 1976, Gut.

[91]  H. Lennernäs,et al.  Investigations of the In‐vitro Metabolism of Three Opioid Tetrapeptides by Pancreatic and Intestinal Enzymes , 2000, The Journal of pharmacy and pharmacology.

[92]  M. Delorenzi,et al.  Changes in the transcriptional profile of transporters in the intestine along the anterior-posterior and crypt-villus axes , 2005, BMC Genomics.

[93]  A. Dawson,et al.  Functional differentiation of human jejunum and ileum: A comparison of the handling of glucose, peptides, and amino acids , 1974, Gut.

[94]  K. Sugano Theoretical investigation of passive intestinal membrane permeability using Monte Carlo method to generate drug-like molecule population. , 2009, International journal of pharmaceutics.

[95]  Kiyohiko Sugano,et al.  Prediction of human intestinal permeability using artificial membrane permeability. , 2003, International journal of pharmaceutics.

[96]  H Lennernäs,et al.  Human intestinal permeability. , 1998, Journal of pharmaceutical sciences.

[97]  A Rostami-Hodjegan,et al.  Absolute abundance and function of intestinal drug transporters: a prerequisite for fully mechanistic in vitro-in vivo extrapolation of oral drug absorption. , 2013, Biopharmaceutics & drug disposition.

[98]  Leslie Z. Benet,et al.  Drug Discovery and Regulatory Considerations for Improving In Silico and In Vitro Predictions that Use Caco-2 as a Surrogate for Human Intestinal Permeability Measurements , 2013, The AAPS Journal.

[99]  D. Blankenhorn,et al.  Transintestinal Intubation , 1955, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[100]  David G Levitt,et al.  PKQuest: measurement of intestinal absorption and first pass metabolism – application to human ethanol pharmacokinetics , 2002, BMC clinical pharmacology.

[101]  H. Lennernäs,et al.  Regional Intestinal Permeability in Rats of Compounds with Different Physicochemical Properties and Transport Mechanisms , 1997, The Journal of pharmacy and pharmacology.

[102]  J. Cerda,et al.  Comparative bioavailability of folate and vitamin C from a synthetic and a natural source. , 1975, The American journal of clinical nutrition.

[103]  T Scior,et al.  How to recognize and workaround pitfalls in QSAR studies: a critical review. , 2009, Current medicinal chemistry.

[104]  P. Artursson,et al.  Comparison of drug transporter gene expression and functionality in Caco-2 cells from 10 different laboratories. , 2008, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[105]  E. Levy,et al.  Short-chain fatty acids: ready for prime time? , 2006, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

[106]  D. Kell,et al.  Carrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule? , 2008, Nature Reviews Drug Discovery.

[107]  D. Levitt Quantitation of small intestinal permeability during normal human drug absorption , 2013, BMC Pharmacology and Toxicology.

[108]  Li Di,et al.  Coexistence of passive and carrier-mediated processes in drug transport , 2010, Nature Reviews Drug Discovery.

[109]  Malcolm Rowland,et al.  PHRMA CPCDC initiative on predictive models of human pharmacokinetics, part 5: prediction of plasma concentration-time profiles in human by using the physiologically-based pharmacokinetic modeling approach. , 2011, Journal of pharmaceutical sciences.

[110]  G. Olaison,et al.  Absorption Profiles for Polyethylene Glycols After Regional Jejunal Perfusion and Oral Load in Healthy Humans , 1997, Digestive Diseases and Sciences.

[111]  D. Roberts,et al.  Development and differentiation of the intestinal epithelium , 2003, Cellular and Molecular Life Sciences CMLS.

[112]  P. Howles,et al.  Development and physiological regulation of intestinal lipid absorption. III. Intestinal transporters and cholesterol absorption. , 2008, American journal of physiology. Gastrointestinal and liver physiology.

[113]  G. Amidon,et al.  Molecular properties of WHO essential drugs and provisional biopharmaceutical classification. , 2004, Molecular pharmaceutics.

[114]  D. Millar,et al.  Intestinal diffusion barrier: unstirred water layer or membrane surface mucous coat? , 1981, Science.

[115]  G. Amidon,et al.  Human Jejunal Permeability of Cyclosporin A: Influence of Surfactants on P-Glycoprotein Efflux in Caco-2 Cells , 2003, Pharmaceutical Research.

[116]  M. Bäckström,et al.  Composition and functional role of the mucus layers in the intestine , 2011, Cellular and Molecular Life Sciences.

[117]  F. Ingelfinger,et al.  A method for studying absorption of water and solute from the human small intestine. , 1968, Gastroenterology.

[118]  D. Loo,et al.  Cotransport of water by the Na+/glucose cotransporter. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[119]  V. Mathan,et al.  Intestinal perfusion studies in tropical sprue. 1. Amino acid and dipeptide absorption. , 1976, Gut.

[120]  V. Mathan,et al.  Xylose transport in the human jejunum , 1989, Digestive Diseases and Sciences.

[121]  A. Falcão,et al.  Optimization of a parallel artificial membrane permeability assay for the fast and simultaneous prediction of human intestinal absorption and plasma protein binding of drug candidates: application to dibenz[b,f]azepine-5-carboxamide derivatives. , 2012, Journal of pharmaceutical sciences.

[122]  C. M. Wood,et al.  Absorption of short-chain fatty acids by the colon. , 1980, Gastroenterology.

[123]  A Rostami-Hodjegan,et al.  Interplay of metabolism and transport in determining oral drug absorption and gut wall metabolism: a simulation assessment using the "Advanced Dissolution, Absorption, Metabolism (ADAM)" model. , 2010, Current drug metabolism.

[124]  G. Amidon,et al.  Analysis of models for determining intestinal wall permeabilities. , 1980, Journal of pharmaceutical sciences.

[125]  H. Lennernäs,et al.  The effect of ketoconazole on the jejunal permeability and CYP3A metabolism of (R/S)-verapamil in humans. , 1999, British journal of clinical pharmacology.

[126]  D. Perrett,et al.  Dipeptide absorption in man , 1972, Gut.

[127]  G. Rechkemmer,et al.  pH-microclimate at the luminal surface of the intestinal mucosa of guinea pig and rat , 1986, Pflügers Archiv.

[128]  Yongjun Hu,et al.  Significance and Regional Dependency of Peptide Transporter (PEPT) 1 in the Intestinal Permeability of Glycylsarcosine: In Situ Single-Pass Perfusion Studies in Wild-Type and Pept1 Knockout Mice , 2010, Drug Metabolism and Disposition.

[129]  Hans Lennernäs,et al.  Regional intestinal drug permeation: biopharmaceutics and drug development. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[130]  V. Andersen,et al.  Human intestinal P‐glycoprotein activity estimated by the model substrate digoxin , 2007, Scandinavian journal of clinical and laboratory investigation.

[131]  J. Rhodes,et al.  The effect of pH and concentration on α‐methyldopa absorption in man , 1986 .

[132]  Inter-relationships between the absorptions of hydrocortisone, sodium, water and actively transported organic solutes in the human jejunum , 2004, European Journal of Clinical Pharmacology.

[133]  S. Masilamani,et al.  Evidence for two different modes of tripeptide disappearance in human intestine. Uptake by peptide carrier systems and hydrolysis by peptide hydrolases. , 1975, The Journal of clinical investigation.

[134]  H Lennernäs,et al.  Jejunal permeability in humans in vivo and rats in situ: investigation of molecular size selectivity and solvent drag. , 1999, Acta physiologica Scandinavica.

[135]  Jahan B. Ghasemi,et al.  Quantitative structure-property relationship study of n-octanol-water partition coefficients of some of diverse drugs using multiple linear regression. , 2007, Analytica chimica acta.

[136]  Anders Karlén,et al.  Hydrogen bonding descriptors in the prediction of human in vivo intestinal permeability. , 2003, Journal of molecular graphics & modelling.

[137]  B Agoram,et al.  Predicting the impact of physiological and biochemical processes on oral drug bioavailability. , 2001, Advanced drug delivery reviews.

[138]  B. Fleshler,et al.  Absorption of glycine and L-alanine by the human jejunum. , 1966, The Journal of clinical investigation.

[139]  G. Cook Effect of glycylglycine and glycine on jejunal absorption rate of L‐histidine in man in vivo , 1974, The Journal of physiology.

[140]  R. Modigliani,et al.  The method of intraluminal perfusion of the human small intestine. 3. Absorption studies in disease. , 1973, Digestion.

[141]  U. Laforenza Water channel proteins in the gastrointestinal tract. , 2012, Molecular aspects of medicine.

[142]  H Lennernäs,et al.  Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach. , 1998, Journal of medicinal chemistry.

[143]  C. Dubray,et al.  Influence of digestive secretions and food on intestinal absorption of nicardipine , 2004, European Journal of Clinical Pharmacology.

[144]  S. Adibi,et al.  Functional characterization of dipeptide transport system in human jejunum. , 1974, The Journal of clinical investigation.

[145]  Hans Lennernäs,et al.  Comparison Between Permeability Coefficients in Rat and Human Jejunum , 1996, Pharmaceutical Research.

[146]  H. Lennernäs,et al.  Intestinal and Hepatobiliary Transport of Ximelagatran and Its Metabolites in Pigs , 2008, Drug Metabolism And Disposition.

[147]  C. M. Wood,et al.  Absorption of short chain fatty acids from the human jejunum. , 1976, Gastroenterology.

[148]  Hans Lennernäs,et al.  The use of biopharmaceutic classification of drugs in drug discovery and development: current status and future extension , 2005, The Journal of pharmacy and pharmacology.

[149]  D. Silk Amino acid and peptide absorption in man. , 2008, Ciba Foundation symposium.

[150]  M. Rongier,et al.  Investigation of drug absorption from the gastrointestinal tract of man. II. Metoprolol in the jejunum and ileum. , 1985, British journal of clinical pharmacology.

[151]  C. M. Wood,et al.  Absorption of short-chain fatty acids from the human ileum , 1977, The American Journal of Digestive Diseases.

[152]  J. Crison,et al.  A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability , 1995, Pharmaceutical Research.

[153]  R. Modigliani,et al.  Validation of the use of a tube with a proximal occlusive balloon for measurement of intestinal absorption in man , 1978, The American Journal of Digestive Diseases.

[154]  H Lennernäs,et al.  Intestinal permeability and its relevance for absorption and elimination , 2007, Xenobiotica; the fate of foreign compounds in biological systems.

[155]  N. Read,et al.  Effect of gastrointestinal intubation on the passage of a solid meal through the stomach and small intestine in humans. , 1983, Gastroenterology.

[156]  Han van de Waterbeemd,et al.  Drug bioavailability : estimation of solubility, permeability, absorption and bioavailability , 2003 .

[157]  P. Raskin,et al.  Effect of intravenous somatostatin on jejunal absorption of glucose, amino acids, water, and electrolytes , 1980 .

[158]  P. Besnard,et al.  Intestinal absorption of long-chain fatty acids: evidence and uncertainties. , 2009, Progress in lipid research.

[159]  Kiyohiko Sugano,et al.  Aqueous boundary layers related to oral absorption of a drug: from dissolution of a drug to carrier mediated transport and intestinal wall metabolism. , 2010, Molecular pharmaceutics.

[160]  M. Rongier,et al.  Intestinal Absorption of Amiodarone in Man , 1990, Journal of clinical pharmacology.

[161]  H. Lennernäs,et al.  Intestinal drug absorption during induced net water absorption in man; a mechanistic study using antipyrine, atenolol and enalaprilat. , 1994, British journal of clinical pharmacology.

[162]  M. Johansson,et al.  The gastrointestinal mucus system in health and disease , 2013, Nature Reviews Gastroenterology &Hepatology.

[163]  Alex Avdeef,et al.  How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability? , 2010, Journal of medicinal chemistry.

[164]  G. Krejs Effect of Somatostatin and Atropine Infusion on Intestinal Transit Time and Fructose Absorption in the Perfused Human Jejunum , 1984, Diabetes.

[165]  K. Luthman,et al.  Caco-2 monolayers in experimental and theoretical predictions of drug transport , 1996 .

[166]  Ganapathy,et al.  Is intestinal peptide transport energized by a proton gradient? , 1985, The American journal of physiology.

[167]  Kairui Feng,et al.  The Simcyp® Population-based ADME Simulator , 2009 .

[168]  Adibi Sa Intestinal transport of dipeptides in man: relative importance of hydrolysis and intact absorption , 1971 .

[169]  S. Phillips,et al.  Active and passive bile acid absorption in man. Perfusion studies of the ileum and jejunum. , 1974, The Journal of clinical investigation.

[170]  Douglas B Kell,et al.  Pharmaceutical drug transport: the issues and the implications that it is essentially carrier-mediated only. , 2011, Drug discovery today.

[171]  G. Amidon,et al.  Physiological parameters for oral delivery and in vitro testing. , 2010, Molecular pharmaceutics.

[172]  G Folkers,et al.  Review of theoretical passive drug absorption models: historical background, recent developments and limitations. , 1996, Pharmaceutica acta Helvetiae.

[173]  H Lennernäs,et al.  Oral biopharmaceutics tools - time for a new initiative - an introduction to the IMI project OrBiTo. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[174]  R. Shulman,et al.  Effects of Timing, Sex, and Age on Site-specific Gastrointestinal Permeability Testing in Children and Adults , 2010, Journal of pediatric gastroenterology and nutrition.

[175]  T. Maurer,et al.  Towards a unified model of passive drug permeation I: origins of the unstirred water layer with applications to ionic permeation. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[176]  S. Riley,et al.  Effects of a non-absorbable osmotic load on drug absorption in healthy volunteers. , 1992, British journal of clinical pharmacology.

[177]  D. Choi,et al.  Drug interaction between oral atorvastatin and verapamil in healthy subjects: effects of atorvastatin on the pharmacokinetics of verapamil and norverapamil , 2008, European Journal of Clinical Pharmacology.

[178]  J. DeSesso,et al.  Anatomical and physiological parameters affecting gastrointestinal absorption in humans and rats. , 2001, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[179]  Ho-Chul Shin,et al.  Why is it Challenging to Predict Intestinal Drug Absorption and Oral Bioavailability in Human Using Rat Model , 2006, Pharmaceutical Research.

[180]  H Lennernäs,et al.  SPR biosensor studies of the direct interaction between 27 drugs and a liposome surface: correlation with fraction absorbed in humans. , 2000, Journal of medicinal chemistry.

[181]  H H USSING,et al.  Active transport of sodium as the source of electric current in the short-circuited isolated frog skin. , 1951, Acta physiologica Scandinavica.

[182]  Kristina Luthman,et al.  Caco-2 monolayers in experimental and theoretical predictions of drug transport1PII of original article: S0169-409X(96)00415-2. The article was originally published in Advanced Drug Delivery Reviews 22 (1996) 67–84.1 , 2001 .

[183]  T. Gramatté Griseofulvin absorption from different sites in the human small intestine , 1994, Biopharmaceutics & drug disposition.

[184]  H. Minami,et al.  Characteristics and mechanism of glutamine-dipeptide absorption in human intestine. , 1992, Gastroenterology.

[185]  M. Rongier,et al.  Evaluation of the gastric absorption and emptying of drugs under various pH conditions using a simple intubation method: application to diclofenac. , 1989, British journal of clinical pharmacology.

[186]  H. Lennernäs,et al.  The effect of L-leucine on the absorption of levodopa, studied by regional jejunal perfusion in man. , 1993, British journal of clinical pharmacology.

[187]  J. Polli,et al.  Rational use of in vitro P-glycoprotein assays in drug discovery. , 2001, The Journal of pharmacology and experimental therapeutics.

[188]  W. Higuchi,et al.  Quantitative mechanistic studies in simultaneous fluid flow and intestinal absorption using steroids as model solutes , 1980 .

[189]  Hans Lennernäs,et al.  EXPERIMENTAL ESTIMATION OF THE EFFECTIVE UNSTIRRED WATER LAYER THICKNESS IN THE HUMAN JEJUNUM, AND ITS IMPORTANCE IN ORAL-DRUG ABSORPTION , 1995 .

[190]  K. Kowdley,et al.  Changes in Small‐Intestine Permeability with Aging , 1995, Journal of the American Geriatrics Society.

[191]  H Lennernäs,et al.  Jejunal permeability and hepatic extraction of fluvastatin in humans , 1996, Clinical pharmacology and therapeutics.

[192]  Neil Parrott,et al.  A Physiologically Based Pharmacokinetic Model of the Minipig: Data Compilation and Model Implementation , 2012, Pharmaceutical Research.

[193]  L. Fändriks,et al.  Surface area of the digestive tract – revisited , 2014, Scandinavian journal of gastroenterology.

[194]  Hans Lennernäs,et al.  Jejunal Absorption and Metabolism of R/S-Verapamil in Humans , 1998, Pharmaceutical Research.

[195]  W. Geber Quantitative measurement of blood flow in various areas of small and large intestine. , 1960, The American journal of physiology.

[196]  Anette Müllertz,et al.  In vitro models for the prediction of in vivo performance of oral dosage forms. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[197]  F. Langenbucher,et al.  In vitro and in vivo deconvolution assessment of drug release kinetics from oxprenolol Oros preparations. , 1985, British journal of clinical pharmacology.

[198]  Friedrich Schuler,et al.  A liposomal fluorescence assay to study permeation kinetics of drug-like weak bases across the lipid bilayer. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[199]  U. Klotz,et al.  Site-dependent small intestinal absorption of ranitidine , 2004, European Journal of Clinical Pharmacology.

[200]  G. Amidon,et al.  Human Intestinal Permeability of Piroxicam, Propranolol, Phenylalanine, and PEG 400 Determined by Jejunal Perfusion , 1997, Pharmaceutical Research.

[201]  D. Levitt,et al.  Use of measurements of ethanol absorption from stomach and intestine to assess human ethanol metabolism. , 1997, The American journal of physiology.

[202]  H. Lennernäs,et al.  FIRST-PASS EFFECTS OF VERAPAMIL ON THE INTESTINAL ABSORPTION AND LIVER DISPOSITION OF FEXOFENADINE IN THE PORCINE MODEL , 2006, Drug Metabolism and Disposition.

[203]  G. Amidon,et al.  Oral Absorption of Peptides: The Effect of Absorption Site and Enzyme Inhibition on the Systemic Availability of Metkephamid , 1994, Pharmaceutical Research.

[204]  N. Vidon,et al.  Jejunal and ileal absorption of oxprenolol in man: influence of nutrients and digestive secretions on jejunal absorption and systemic availability. , 1987, British journal of clinical pharmacology.

[205]  U. Hofmann,et al.  Increased Absorption of Digoxin from the Human Jejunum Due to Inhibition of Intestinal Transporter-Mediated Efflux , 2007, Clinical pharmacokinetics.

[206]  M. Kataoka,et al.  Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[207]  B. Johnson,et al.  A completely absorbed oral preparation of digoxin , 1976, Clinical pharmacology and therapy.

[208]  H. Lennernäs,et al.  Regional Jejunal Perfusion, a New in Vivo Approach to Study Oral Drug Absorption in Man , 1995, Pharmaceutical Research.

[209]  S. Nylander,et al.  Jejunal Permeability: A Comparison Between the Ussing Chamber Technique and the Single-Pass Perfusion in Humans , 1997, Pharmaceutical Research.

[210]  H. Said Intestinal absorption of water-soluble vitamins in health and disease. , 2011, The Biochemical journal.

[211]  M. Barzegar-Jalali,et al.  Predicting human intestinal permeability using single-pass intestinal perfusion in rat. , 2007, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[212]  K. Luthman,et al.  Evaluation of dynamic polar molecular surface area as predictor of drug absorption: comparison with other computational and experimental predictors. , 1998, Journal of medicinal chemistry.

[213]  D. Azarnoff,et al.  Absorption of orally given digoxin preparations. , 1972, JAMA.

[214]  G. Amidon,et al.  A Residence‐Time Distribution Analysis of the Hydrodynamics within the Intestine in Man during a Regional Single‐pass Perfusion with Loc‐I‐Gut: In‐vivo Permeability Estimation , 1997, The Journal of pharmacy and pharmacology.

[215]  G. Amidon,et al.  The effect of amiloride on the in vivo effective permeability of amoxicillin in human jejunum: experience from a regional perfusion technique. , 2002, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.